US Plant Ruins 15 Million Johnson & Johnson Coronavirus Vaccine Doses, Says Report

By
vipulpatil40
-
0
44


(*15*)

This July 2020 picture supplied by Johnson & Johnson reveals a vial of the COVID-19 vaccine. (AP)

The firm stated the batch “was never advanced to the filling and finishing stages of our manufacturing process.”

  • AFP Washington
  • Last Updated:April 01, 2021, 08:06 IST
  • FOLLOW US ON:

About 15 million doses of the single-shot coronavirus vaccine made by Johnson & Johnson had been ruined in a manufacturing unit error within the United States, The New York Times reported — a blow to the corporate’s efforts to shortly enhance manufacturing.

When contacted by AFP, the pharmaceutical big stated it had recognized a batch of doses at a plant in Baltimore run by Emergent BioSolutions “that did not meet quality standards” however didn’t verify the precise quantity affected.

The firm additionally stated the batch “was never advanced to the filling and finishing stages of our manufacturing process.”

“Quality and safety continue to be our top priority,” it stated.

The Times report nevertheless signaled that points with high quality management may have an effect on future output, with the Food and Drug Administration anticipated to research.

The FDA informed AFP it was “aware of the situation” however declined to remark additional.

Johnson & Johnson stated it was sending extra consultants to the location to “supervise, direct and support all manufacturing of the Johnson & Johnson COVID-19 vaccine,” which might permit it to ship a further 24 million pictures “through April.”

The Emergent BioSolutions plant had not but been licensed by US regulators to fabricate a “drug substance” for the J&J vaccine, the corporate stated, however US media reported that it was anticipated to supply tens of hundreds of thousands of doses within the close to future.

The J&J vaccine has gained reward for its single dosage and since it doesn’t must be frozen — not like the pictures from Moderna and Pfizer — making distribution a lot easier.

“We continue to expect to deliver our Covid-19 vaccine at a rate of more than one billion doses by the end of 2021,” J&J stated.



Source hyperlink